VectivBio | Results Presentation Deck

VectivBio | Results Presentation Deck | 9 slides

VectivBio · 2022-10

arc beats above · slides in the middle · loops below · scroll → 2 LOOPS

Deck intelligence map

coverage by narrative range · generated from this deck JSON

Narrative range 9 total

Metadata

Components

Metrics

Tools

Frameworks

Beats

Loops

Setup 2 slides 100% 2/2 slides 100% 2/2 slides · 4 hits

— 0/2 slides

50% 1/2 slides

— 0/2 slides

100% 2/2 slides

— 0/2 slides

Complication 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits

— 0/1 slides

100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Evidence 3 slides 100% 3/3 slides 100% 3/3 slides · 8 hits

— 0/3 slides

66.7% 2/3 slides

— 0/3 slides

100% 3/3 slides 100% 3/3 slides · 6 hits Key Takeaways 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits

— 0/1 slides

100% 1/1 slides

— 0/1 slides

100% 1/1 slides 100% 1/1 slides Appendix 2 slides 100% 2/2 slides 100% 2/2 slides · 4 hits

— 0/2 slides

100% 2/2 slides

— 0/2 slides

Slide inventory

every slide · same image gating as the playbook

front_matter

Open slide detailBeat · Setup

other

Open slide detailBeat · Setup

The slide uses a timeline-based study design diagram to illustrate the clinical trial phases.present_solution

Open slide detailBeat · ComplicationLoop · Cost Of Inaction

analyze_data

Open slide detailBeat · EvidenceLoop · Cost Of Inaction

The chart tracks clinical trial data showing efficacy over time.analyze_data

Open slide detailBeat · EvidenceLoop · Cost Of Inaction

The chart tracks clinical response defined as >20% PS reduction. Sample sizes decrease from n=9 at month 0 to n=5 at month 6.analyze_data

Open slide detailBeat · EvidenceLoop · Cost Of Inaction

PS likely refers to Parenteral Support.summarize

Open slide detailBeat · Key TakeawaysLoop · Voice Of Customer

appendix

Open slide detailBeat · Appendix

The slide includes a disclaimer that the data is not intended to demonstrate comparative efficacy.compare_peers

Open slide detailBeat · Appendix